Results 151 to 160 of about 76,053 (241)

Preventive and Therapeutic Interventions for Anticancer Drug-induced Dermatologic Toxicities: a Scoping Review. [PDF]

Curr Oncol Rep
Iimura Y, Kuroda S.
europepmc   +1 more source

Cost-effectiveness of DPYD genotyping prior to capecitabine administration for metastatic breast cancer. [PDF]

Breast Cancer Res Treat
Chiddarwar T, Blaes A, Kuntz K.
europepmc   +1 more source

Cost-effectiveness of switching to S-1 after fluoropyrimidine-induced hand-foot syndrome or cardiovascular toxicity in the treatment of metastatic colorectal cancer. [PDF]

ESMO Open
van Eekelen R, Punt CJA, Kwakman JJM, Coupé VMH.   +3 more
europepmc   +1 more source

AGO Recommendations for Diagnosis and Treatment of Patients with Early and Metastatic Breast Cancer: Update 2012 [PDF]

, 2011
Harbeck, Nadia, Scharl, Anton, Thomssen, Christoph   +2 more
core   +2 more sources

Clinical Validation of Digital PCR-Based ctDNA Detection for Risk Stratification in Residual Triple-Negative Breast Cancer: TRICIA Trial Results. [PDF]

Clin Cancer Res
Roseshter T, Klemantovich A, Lafleur J, Lan C, Cavallone L, Bozek K, Guay J, Elebute O, Jenna S, Ouellette R, McNamara S, Boileau JF, Pelmus M, Brackstone M, Pezo R, Ng T, Aguilar-Mahecha A, Basik M.   +17 more
europepmc   +1 more source

Capecitabine combined with fecal microbiota transplantation prevents colorectal cancer progression through correction of microbial dysbiosis and immune regulation. [PDF]

Sci Rep
Arshad M, Zhang CY, Gao ZK, Sun H, Xu DQ, Fan CY, Zhang BW, Geng JX, Li Y, Kotusov A, Liu SL, Zhang N, Mu XQ.   +12 more
europepmc   +1 more source

Usefulness of pharmacy outpatient clinic follow-up for maintaining relative dose intensity in patients on adjuvant CAPOX chemotherapy for gastric cancer. [PDF]

Mol Clin Oncol
Nakamura M, Yokokawa T, Kawakami K, Kimura Y, Shimizu H, Kobayashi K, Aoyama T, Suzuki W, Hatori M, Suzuki K, Takahari D, Ogura M, Chin K, Wakatsuki T, Yamaguchi K, Yamaguchi M.   +15 more
europepmc   +1 more source

Phase-Tuning of Ru Nanostructures in Ru/ZrO₂ Catalysts for Controlling Radical and Nonradical Pathways of Peroxymonosulfate-Based Oxidation and Defluorination of a Fluorinated Anticancer Drug. [PDF]

ACS Appl Mater Interfaces
Park J, Bae S, Choi Y, Choe JK.
europepmc   +1 more source

Capecitabine Dosage as an Independent Prognostic Factor for the Development of Hand-Foot Syndrome: A Competing Risk Analysis. [PDF]

Drug Healthc Patient Saf
Chantharakhit C, Patumanond J, Phinyo P, Chai-Adisaksopha C.   +3 more
europepmc   +1 more source

Case Report: Sustained complete response achieved in a patient with advanced HER-2 positive gastric cancer after 4 years of chemotherapy-free treatment. [PDF]

Front Oncol
Tong X, Peng J, Liu B.
europepmc   +1 more source